Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New

Related Keywords

Mexico ,United Kingdom ,Australia ,New Zealand ,India ,Canada ,Zealand Medsafe ,Laura Keenan ,Stanleyc Erck ,Biocelect Pty ,Mediaalison Chartan ,Solebury Troutalexandra Roy ,Linkedin ,Twitter ,Investorsnovavax Inc Erika Schultz ,World Health Organization ,Nasdaq ,Novavaxnovavax Inc ,Exchange Commission ,Serum Institute Of India Pvt ,European Union ,Devices Safety Authority Medsafe ,New Zealand Medicines ,Medical Devices Safety Authority ,Chief Executive Officer ,Serum Institute ,Emergency Use Listing ,Looking Statementsstatements ,Financial Condition ,Novavax Annual Report ,Quarterly Reports ,Inc Erika Schultz ,Troutalexandra Roy ,Alison Chartan ,